The LOI submission period for the 2018 funding cycle has closed. For updates on future funding opportunities please sign up for our mailing list below.
Focus for 2018’s Research Funding Round: Biomarkers
BDSRA seeks letters of intent from the Batten and larger lysosomal disease research community for innovative technologies in biomarkers for any of the 14 forms of Batten disease. Development of, or improvement of biomarkers using tissue, blood, urine or imaging are welcome, as are new concepts in development.
As always, the scientific merit of projects is paramount. We also greatly encourage projects that will pull together multiple funding sources, cross-lab collaborations, and projects that have promise of future NIH, DOD or other government, or industry funding.
LOI guidelines can be found here.
Please contact us at email@example.com if you have any questions.